Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • About us
    • About the Access Campaign
    • Media room
    • Latest news
    • Jobs

    Public support helps expand access to life-saving care and treatment.

    Sign up for our newsletter and receive updates on our advocacy and campaigning.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Our work
    • Drug-resistant infections
    • HIV/AIDS
    • Hepatitis C
    • Patents and intellectual property
      • Spotlight on: RCEP trade agreement
    • Research and development
    • Tropical and neglected diseases
    • Tuberculosis
    • Vaccines
      • A Fair Shot campaign

    Public support helps expand access to life-saving care and treatment.

    Sign up for our newsletter and receive updates on our advocacy and campaigning.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Get involved
    • Active campaigns
      • #HelpMakeTBhistory
      • A Fair Shot campaign
      • Hands off our medicines
    • Campaign success stories
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    Take Action

    When you join one of our public campaigns, you work with MSF to save lives.

  • Resources
    • Events
    • Feature stories
    • Infographics
    • Interviews
    • Letters
    • Opinion articles
    • Photo stories
    • Press releases
    • Publications
      • Fact sheets
      • Issue briefs
      • Reports
      • Report series
      • Technical briefs
      • All types
    • Research articles
    • Statements
    • Topic overview pages
    • Spotlight pages
    • Videos

    Public support helps expand access to life-saving care and treatment.

    Sign up for our newsletter and receive updates on our advocacy and campaigning.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Media room
  • Contact
  • msf.org
  • About us
    • About the Access Campaign
    • Media room
    • Latest news
    • Jobs

    Public support helps expand access to life-saving care and treatment.

    Sign up for our newsletter and receive updates on our advocacy and campaigning.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Our work
    • Drug-resistant infections
    • HIV/AIDS
    • Hepatitis C
    • Patents and intellectual property
      • Spotlight on: RCEP trade agreement
    • Research and development
    • Tropical and neglected diseases
    • Tuberculosis
    • Vaccines
      • A Fair Shot campaign

    Public support helps expand access to life-saving care and treatment.

    Sign up for our newsletter and receive updates on our advocacy and campaigning.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Get involved
    • Active campaigns
      • #HelpMakeTBhistory
      • A Fair Shot campaign
      • Hands off our medicines
    • Campaign success stories
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    Take Action

    When you join one of our public campaigns, you work with MSF to save lives.

  • Resources
    • Events
    • Feature stories
    • Infographics
    • Interviews
    • Letters
    • Opinion articles
    • Photo stories
    • Press releases
    • Publications
      • Fact sheets
      • Issue briefs
      • Reports
      • Report series
      • Technical briefs
      • All types
    • Research articles
    • Statements
    • Topic overview pages
    • Spotlight pages
    • Videos

    Public support helps expand access to life-saving care and treatment.

    Sign up for our newsletter and receive updates on our advocacy and campaigning.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury

Take action!
Get involved
The existing treatment lasts at least two years including several months in hospital. The treatment at the special drug resistant TB unit on the outskirts of Yerevan means having to take up to 20 pills a day, often together with painful injections every morning.

How is it possible...

...that we sent people to the moon almost 50 years ago, yet millions of people with tuberculosis are still treated with old, inadequate medicines?

https://tbsummit.msfaccess.org/

MSF and generic medicines

97% of the medicines MSF uses to treat people with HIV are generics made in India.
94% of the medicines MSF uses to treat people with HIV, TB, malaria and other infections diseases are generics.
2/3 of the medicines MSF uses to treat people with TB, HIV and malaria are generics made in India.

Don't miss out!

Sign up for our newsletter and receive updates on our advocacy and campaigning.

I want to receive emails from MSF and I have read and agree with the privacy policy.

Tags
Intellectual property and trade drug-resistant TBHIV/AIDS free trade agreementgeneric medicinesRegional Comprehensive Economic Partnership (RCEP)

Navigate

  • About the Access Campaign
  • Contact
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search

Get updates

  • Sign up for our newsletter
  • Privacy & data protection information

Contact

MSF Access Campaign
Médecins Sans Frontières
Rue de Lausanne 78
P.O Box 1016
CH-1211 Geneva 1, Switzerland
Phone:+41 22 849 8484 Fax:+41 22 849 8404
E-mail: access(at)msf.org

Follow us on Twitter and Facebook

  • Facebook
  • Twitter
  • Vimeo
Medicines Shouldn't Be A Luxury